Phosphorylated-p38 mitogen-activated protein kinase expression is associated with clinical factors in invasive breast cancer

Bin Wang(Hebei Medical University), Yajie Wang(Second Military Medical University)
SpringerPlus
June 30, 2016
10.1186/s40064-016-2636-0
Cited by 17

Related Papers

Targeting the tumor microenvironment with biomaterials for enhanced immunotherapeutic efficacy
|Journal of Nanobiotechnology|2024|48
MiR-155 deficiency protects renal tubular epithelial cells from telomeric and genomic DNA damage in cisplatin-induced acute kidney injury
|Theranostics|2022|42
Mitochondrial transcription factor A contributes to cisplatin resistance in patients with estrogen receptor-positive breast cancer
|Molecular Medicine Reports|2016|25
Insights Into the Separate and Joint Effects of Cadmium and Cesium on the Risk of Circadian Syndrome and the Underlying Mechanism: An Integrated Epidemiological and Network Toxicological Study
|Biological Trace Element Research|2025|1
Supplementary Figure S1,Figure S2,Figure S3,Table S1，Table S2，Table S3，and Table S4. from <i>MPO</i> Promoter Polymorphism rs2333227 Enhances Malignant Phenotypes of Colorectal Cancer by Altering the Binding Affinity of AP-2α
|Unknown|2023|0